GlassScriptPhysician profile
Junaid Akbar
NPI 1023758497
$2,565.62
in general payments reported to CMS, 2019-2025
8 companies · $2,566 in 2025
The $2,566 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,445 · Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,445.28 |
| Food and Beverage | $1,120.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,386.12 | 2025 | Portfolio, Precision Mis Bunion |
| Integra Lifesciences Corporation | $502.21 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $245.50 | 2025 | Variax, Ortholoc 2 Lapifuse, Prostep Mica |
| Smith+Nephew, INC. | $188.55 | 2025 | Q-Fix, Healicoil, Renasys Touch |
| Acera Surgical, INC. | $157.82 | 2025 | Restrata Wound Matrix |
| Treace Medical Concepts, INC. | $44.02 | 2025 | |
| Amgen INC. | $26.36 | 2025 | Krystexxa |
| Orthofix Medical, INC. | $15.04 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junaid Akbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.